Viral Clearance Market by Method (Viral Removal, Viral Inactivation), Application (Blood, Recombinant Proteins, Vaccines), End User (CROs, Pharmaceutical & Biotechnology Companies) – 2021 to 2026

$3,850.00$5,850.00

Published on: July 23, 2021
Clear
SKU: GMS-2057 Category:

OVERVIEW

The global market for virus filtration is expected to hit USD 6.12 billion by 2025, rising between 2020 and 2025 at a CAGR of 11.1 per cent. The major market drivers include growing R&D spending, biopharmaceutical industry expansion, and increasing government funding for the pharmaceutical and biotechnology industries.

Viral Clearance Market by Method (Viral Removal, Viral Inactivation), Application (Blood, Recombinant Proteins, Vaccines), End User (CROs, Pharmaceutical & Biotechnology Companies) - 2021 to 2026 1

Viral Clearance Market by Method (Viral Removal, Viral Inactivation), Application (Blood, Recombinant Proteins, Vaccines), End User (CROs, Pharmaceutical & Biotechnology Companies) - 2021 to 2026 2

Viral Clearance Market by Method (Viral Removal, Viral Inactivation), Application (Blood, Recombinant Proteins, Vaccines), End User (CROs, Pharmaceutical & Biotechnology Companies) - 2021 to 2026 3

Viral Clearance Market by Method (Viral Removal, Viral Inactivation), Application (Blood, Recombinant Proteins, Vaccines), End User (CROs, Pharmaceutical & Biotechnology Companies) - 2021 to 2026 4

Viral Clearance Market by Method (Viral Removal, Viral Inactivation), Application (Blood, Recombinant Proteins, Vaccines), End User (CROs, Pharmaceutical & Biotechnology Companies) - 2021 to 2026 5

Viral Clearance Market by Method (Viral Removal, Viral Inactivation), Application (Blood, Recombinant Proteins, Vaccines), End User (CROs, Pharmaceutical & Biotechnology Companies) - 2021 to 2026 6

Viral Clearance Market by Method (Viral Removal, Viral Inactivation), Application (Blood, Recombinant Proteins, Vaccines), End User (CROs, Pharmaceutical & Biotechnology Companies) - 2021 to 2026 7

Viral Clearance Market by Method (Viral Removal, Viral Inactivation), Application (Blood, Recombinant Proteins, Vaccines), End User (CROs, Pharmaceutical & Biotechnology Companies) - 2021 to 2026 8

TABLE OF CONTENT

1 Global Viral Clearance Market – Overview
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries

2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Viral Clearance Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
3.4 Top 5 Financials Analysis
4 Global Viral Clearance Market – Market Forces
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Challenges
4.3 Porters Analysis of Market

4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5 Global Viral Clearance Market – By Method (Market Size – & million/billion)
5.1 Viral Removal
5.2 Chromatography
5.3 Nanofiltration
5.4 Precipitation
5.5 Viral Inactivation
5.6 Low pH
5.7 Solvent Detergent Method
5.8 Pasteurization
5.9 Other
6 Global Viral Clearance Market – By Application
6.1 Recombinant Proteins
6.2 Blood and Blood Products
6.3 Vaccines
6.4 Other
7 Global Viral Clearance Market – By End-User
7.1 Pharmaceutical & Biotechnology Companies
7.2 Contract Research Organizations
7.3 Academic Research Institutes
7.4 Other
8 Global Viral Clearance Market – By Geography (Market Size – & million/billion)
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 U.K

8.3.2 Germany
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia-Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 South Korea
8.4.5 Rest of APAC
8.5 Rest of the World
8.5.1 South America
8.5.2 Middle East
8.5.3 Africa
9 Global Viral Clearance Market – Entropy
9.1 New product launches
9.2 M&A's, collaborations, JVs and partnerships
10 Global Viral Clearance Market Company Profile (Key Players)
10.1 Market Share, Company Revenue, Products, M&A, Developments
10.2 Wuxi Biologics (Cayman) (Subsidiary of Wuxi Apptec)
10.3 Merck KGaA
10.4 Clean Cells
10.5 Bsl Bioservice
10.6 Virusure GmbH
10.7 Charles River Laboratories International
10.8 Texcell
10.9 Kedrion
10.10 Vironova Biosafety
10.11 Company 10
10.12 Company 11 & more
11 Global Viral Clearance Market – Appendix
11.1 Sources

11.2 Abbreviations